Register for free to
view the full innovation profile.
Self-care app and inhaler tracker for 6-12yrs with severe-to-moderate asthma for both child and parent/carer. Currently developing AI for enhanced expertise for parents and child.
About
Asthma+me was co-designed with a Paediatrician at an NHS Trust (UK) supporting the transition from treatment in specialist paediatric clinics to community care, with initial focus on meeting the needs of children aged 6-12years with moderate-to-severe asthma. Supports wireless medical monitors, medication diaries, trigger alerts for pollution/pollen/weather, symptoms tracking, care plan, extensive educational syllabus and weekly reports going directly to their hospital records. Current development and integration of AI during an RCT will significantly enhance the solution allowing disease status reporting to specialist clinic, less clinician time, improved medication adherence, improved self-confidence and in-built expertise for patients and parents.
Key Benefits
What is unique about it? Current development and integration of AI components during the RCT will significantly enhance the solution allowing disease status reporting to the specialist clinic, less clinician time and in-built expertise for patients and parents. The Asthma+me App is the first remote monitoring self-management solution in paediatric clinical trials, that allows risk stratification on need, a personalised-care approach, thereby reducing emergency admissions, improving patient safety and quality-of-life. How does it benefit clinicians and patients? Lack of medication adherence is a global problem, with £300million worth of medications/year wasted in primary care, with 50% of patients are not taking their medication as prescribed. Asthma is the most common chronic medical condition among UK Children/Young People. The cost associated with treating all types of asthma is significant. In the UK 10% of children with asthma are clinically-defined as moderate-to-severe or difficult-to-treat asthma and should be treated in specialist paediatric hospital clinics. There are no current comparators to Asthma+me worldwide. What healthcare system need does your product meet? Reducing Outpatient Appointments at tertiary hospital clinics for moderate-to-severe asthmatic children 6-12 years, so that more first appointments can be provided to other children. It also assists with medication adherence, education, improved self-confidence in self-care of childhood asthma, reduction of admissions and improved use of NHS resources.
Applications
Asthma+me was co-designed with a Paediatrician at an NHS Trust (UK) supporting the transition from treatment in specialist paediatric clinics to community care, with an initial focus on meeting the needs of children aged 6-12 years with moderate-to-severe asthma. It supports wireless medical monitors, medication diaries, trigger alerts for pollution/pollen/weather, symptoms tracking, care plan, an extensive educational syllabus and weekly reports going directly to their hospital records. The Asthma+me App is used with the Activ8rlives PUFFClickerTM smart tracker for pressurised metered-dose inhalers pMDIs, counting doses, recording inhaler shaken properly and timer supporting improved inhaler technique. Asthma+me provides basic disease monitoring via connected devices, patient and parent/carer education, medication adherence, motivational support through self-care to reduce severity of asthma attacks, reducing A&E and hospital admissions. Children are involved in setting their goals and are motivated by incentives from parent/carer to promote behaviour change, increasing adherence to their Care Plan, which is generated automatically on their Smartphone. The Asthma+me App and Activ8rlives PUFFClicker Smart Inhaler Tracker are both approved as Class 1 Medical Devices under MDD and the Asthma+me App will transition to MDR as a Class IIa medical devices through a UK Notified Body.